[Alterations of urinary excretion of antipyrine metabolites in patients with cirrhosis of the liver].
Noda
S
S
Kawata
S
S
Ito
N
N
Miyoshi
S
S
Imai
Y
Y
Saitoh
R
R
Tamura
S
S
Inada
M
M
Inui
Y
Y
Matsuda
Y
Y
D000983:Antipyrine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D006528:Carcinoma, Hepatocellular / Q000150:complications; D000077553:Edaravone; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000652:urine*; D008113:Liver Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged
C007983:4-hydroxyantipyrine; C031820:3-hydroxymethylantipyrine; D000077553:Edaravone; D000983:Antipyrine